社团 发表于 2025-3-23 13:20:05

Submitted on: 07 September 2019.
Revised on: 09 November 2019.
Accepted on: 26 November 2019.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

不妥协 发表于 2025-3-23 16:13:01

Submitted on: 15 November 2012.
Revised on: 21 February 2013.
Accepted on: 23 March 2013.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

Ingenuity 发表于 2025-3-23 18:27:49

Submitted on: 02 November 2014.
Revised on: 31 January 2015.
Accepted on: 21 March 2015.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

隼鹰 发表于 2025-3-23 23:54:50

Submitted on: 29 April 2023.
Revised on: 10 June 2023.
Accepted on: 19 July 2023.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

fatty-acids 发表于 2025-3-24 06:26:02

http://reply.papertrans.cn/1/94/9342/9342-15.png

Compass 发表于 2025-3-24 07:10:23

http://reply.papertrans.cn/1/94/9342/9342-16.png

fiscal 发表于 2025-3-24 11:34:52

Submitted on: 23 August 2015.
Revised on: 16 September 2015.
Accepted on: 08 November 2015.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

军火 发表于 2025-3-24 17:00:48

Submitted on: 12 December 1998.
Revised on: 29 January 1999.
Accepted on: 10 March 1999.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

Vital-Signs 发表于 2025-3-24 20:03:07

Submitted on: 26 April 1999.
Revised on: 24 August 1999.
Accepted on: 06 September 1999.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

vibrant 发表于 2025-3-24 23:42:55

Submitted on: 20 April 2001.
Revised on: 18 May 2001.
Accepted on: 09 July 2001.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY
页: 1 [2] 3 4
查看完整版本: SCIE期刊EUROPEAN NEUROPSYCHOPHARMACOLOGY 2024/2025影响因子:6.196 (EUR NEUROPSYCHOPHARM) (0924-977X). (CLINICAL NEUROLOGY)(临床神